36 | LipidsIBA
12/2023
-
05/2003 |
18 | Unsaturated Fatty Acids (Polyunsaturated Fatty Acids)IBA
01/2023
-
09/2007 |
18 | Eicosapentaenoic AcidIBA
01/2022
-
03/2005 |
12 | 5S,12R,18R- trihydroxy- 6Z,8E,10E,14Z,16E- eicosapentaenoic acidIBA
10/2015
-
03/2005 |
10 | Fatty Acids (Saturated Fatty Acids)IBA
01/2023
-
03/2005 |
9 | Omega-3 Fatty Acids (Omega 3 Fatty Acids)IBA
01/2023
-
12/2010 |
9 | ZymosanIBA
12/2014
-
08/2006 |
7 | Docosahexaenoic AcidsIBA
01/2023
-
09/2009 |
7 | Aspirin (Acetylsalicylic Acid)FDA LinkGeneric
10/2020
-
05/2003 |
6 | CytokinesIBA
09/2023
-
08/2009 |
6 | LipoxinsIBA
10/2012
-
05/2003 |
5 | Proteins (Proteins, Gene)FDA Link
01/2023
-
05/2003 |
4 | Dextran SulfateIBA
01/2023
-
01/2010 |
4 | Dinoprostone (PGE2)FDA Link
01/2022
-
04/2003 |
4 | Arachidonic Acid (Vitamin F)IBA
01/2019
-
09/2007 |
3 | EnzymesIBA
04/2024
-
06/2013 |
3 | Anti-Bacterial Agents (Antibiotics)IBA
10/2023
-
04/2014 |
3 | Arachidonate 15-Lipoxygenase (Arachidonate 15 Lipoxygenase)IBA
01/2021
-
01/2013 |
3 | Anti-Allergic Agents (Antiallergic Agents)IBA
11/2019
-
06/2015 |
3 | 17,18-epoxy-5,8,11,14-eicosatetraenoic acidIBA
01/2018
-
02/2014 |
3 | EicosanoidsIBA
11/2017
-
05/2013 |
3 | AcidsIBA
08/2015
-
01/2010 |
3 | Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
01/2015
-
05/2005 |
3 | lipoxin A4IBA
09/2014
-
02/2010 |
3 | protectin D1IBA
03/2013
-
06/2007 |
2 | CarbohydratesIBA
09/2023
-
01/2023 |
2 | Insulin (Novolin)FDA Link
09/2023
-
12/2010 |
2 | Biomarkers (Surrogate Marker)IBA
01/2023
-
01/2021 |
2 | G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA
01/2023
-
01/2018 |
2 | AutacoidsIBA
01/2023
-
09/2005 |
2 | CeramidesIBA
01/2023
-
01/2021 |
2 | HaptensIBA
01/2022
-
06/2013 |
2 | ChemokinesIBA
01/2022
-
01/2016 |
2 | Secretory Phospholipases A2IBA
01/2022
-
06/2013 |
2 | Phospholipases (Phospholipase)IBA
01/2022
-
01/2017 |
2 | Amyloid (Amyloid Fibrils)IBA
06/2021
-
05/2013 |
2 | Matrix Metalloproteinases (MMPs)IBA
06/2021
-
01/2014 |
2 | Prostaglandin D2IBA
05/2021
-
05/2013 |
2 | InterleukinsIBA
01/2021
-
03/2005 |
2 | Phospholipids (Phosphatides)FDA LinkGeneric
01/2021
-
11/2017 |
2 | Interleukin-17 (Interleukin 17)IBA
01/2021
-
01/2018 |
2 | CholesterolIBA
01/2021
-
11/2014 |
2 | LigandsIBA
01/2019
-
01/2010 |
2 | Leukotriene B4IBA
01/2018
-
04/2003 |
2 | Fish OilsIBA
01/2015
-
03/2005 |
2 | SteroidsIBA
01/2015
-
09/2014 |
2 | Interleukin-12 (IL 12)IBA
05/2005
-
03/2005 |
1 | GlycolipidsIBA
04/2024 |
1 | alkylglycerone-phosphate synthaseIBA
04/2024 |
1 | GalactosyltransferasesIBA
04/2024 |
1 | Uridine Diphosphate (UDP)IBA
04/2024 |
1 | hexadecanal dehydrogenase (acylating) (fatty acyl-CoA reductase)IBA
04/2024 |
1 | Glucosylceramidase (Glucocerebrosidase)IBA
12/2023 |
1 | Glucosylceramides (Glucocerebrosides)IBA
12/2023 |
1 | Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA
12/2023 |
1 | gluconic acid (gluconate)FDA LinkGeneric
10/2023 |
1 | SolutionsIBA
10/2023 |
1 | MonosaccharidesIBA
09/2023 |
1 | 7,14- dihydroxydocosa- 4,8,10,12,16,19- hexaenoic acidIBA
01/2023 |
1 | resolvin D1IBA
01/2023 |